Simpler Grants.gov #RFA-AI-27-002

NIH Infectious Diseases Clinical Trials Network (IDCTN) Cooperative Agreement Opportunity

This opportunity from the National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), seeks to establish a clinical trials network for infectious diseases research. - Government Buyer: - National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID) - Scope: - Establishment of a cooperative network for rapid implementation of clinical trials - Network will include Clinical Trial Evaluation Units (CTEUs) and a Network Coordination Center (NCC) - Focus on evaluation of therapeutics, vaccines, biologics, diagnostics, and devices for both emerging and chronic infectious diseases - Products/Services Requested: - No specific products, part numbers, or OEMs are named - Services include network coordination, administrative support, expert engagement, and mentoring for clinical trialists - Notable Requirements: - Broad eligibility: small businesses, educational institutions, government entities, nonprofits, tribal organizations, and community-based organizations - Emphasis on rapid response and infrastructure for clinical research - Estimated funding amount is $29,000,000 - No unique product requirements or part numbers specified, as this is a grant for research infrastructure and coordination

Description

The National Institute of Allergy and Infectious Diseases (NIAID) seeks to support a cooperative network to rapidly implement clinical trials that meet NIH and NIAID priorities. The network includes Clinical Trial Evaluation Units (CTEUs) and a Network Coordination Center (NCC) to evaluate therapeutics, vaccines, biologics, diagnostics, and devices targeting infectious diseases. This initiative enables the NIH to conduct clinical trials and studies for public health priorities with timelines faster than standard grants. The NCC provides administrative and organizational support and engages experts to generate innovative concepts while mentoring clinical trialists.

View original listing